Vähäkangas K - Search Results

1

Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital.

Raunio H, Kojo A, Juvonen R, Honkakoski P, Järvinen P, Lang MA, Vähäkangas K, Gelboin HV, Park SS, Pelkonen O. Raunio H, et al. Among authors: vahakangas k. Biochem Pharmacol. 1988 Nov 1;37(21):4141-7. doi: 10.1016/0006-2952(88)90108-6. Biochem Pharmacol. 1988. PMID: 2903743

2

Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2.

Vähäkangas K, Raunio H, Pasanen M, Sivonen P, Park SS, Gelboin HV, Pelkonen O. Vähäkangas K, et al. J Biochem Toxicol. 1989 Summer;4(2):79-86. doi: 10.1002/jbt.2570040203. J Biochem Toxicol. 1989. PMID: 2512389

3

Involvement of P450 1A1 in benzo(a)pyrene but not in benzo(a)pyrene-7,8-dihydrodiol activation by 3-methylcholanthrene-induced mouse liver microsomes.

Bjelogrlic N, Peng R, Park SS, Gelboin HV, Honkakoski P, Pelkonen O, Vähäkangas K. Bjelogrlic N, et al. Among authors: vahakangas k. Pharmacol Toxicol. 1993 Dec;73(6):319-24. doi: 10.1111/j.1600-0773.1993.tb01359.x. Pharmacol Toxicol. 1993. PMID: 8153055

4

The effects of harman and norharman on the metabolism of benzo(a)pyrene in isolated perfused rat lung and in rat lung microsomes.

Vähäkangas K, Pelkonen O. Vähäkangas K, et al. Biochem Pharmacol. 1979 May 15;28(10):1591-6. doi: 10.1016/0006-2952(79)90170-9. Biochem Pharmacol. 1979. PMID: 475820 No abstract available.

5

Benzo[a]pyrene-DNA-adducts and monooxygenase activities in mice treated with benzo[a]pyrene, cigarette smoke or cigarette smoke condensate.

Bjelogrlic N, Iscan M, Raunio H, Pelkonen O, Vähäkangas K. Bjelogrlic N, et al. Among authors: vahakangas k. Chem Biol Interact. 1989;70(1-2):51-61. doi: 10.1016/0009-2797(89)90062-8. Chem Biol Interact. 1989. PMID: 2786769

6

Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells.

Salonpää P, Hakkola J, Pasanen M, Pelkonen O, Vähäkangas K, Battula N, Nouso K, Raunio H. Salonpää P, et al. Among authors: vahakangas k. Eur J Pharmacol. 1993 Aug 2;248(2):95-102. doi: 10.1016/0926-6917(93)90030-t. Eur J Pharmacol. 1993. PMID: 8223969

7

Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.

Hakkola J, Raunio H, Purkunen R, Saarikoski S, Vähäkangas K, Pelkonen O, Edwards RJ, Boobis AR, Pasanen M. Hakkola J, et al. Among authors: vahakangas k. Biol Neonate. 2001;80(3):193-201. doi: 10.1159/000047142. Biol Neonate. 2001. PMID: 11585982

8

[Biochemical study procedures for verifying non-smoking: evaluating the usefulness of biochemical indicators of exposure to cigarette smoke].

Vähäkangas K, Pelkonen O. Vähäkangas K, et al. Z Arztl Fortbild (Jena). 1989;83(21):1061-4. Z Arztl Fortbild (Jena). 1989. PMID: 2698551 Review. German. No abstract available.

9

Synchronous fluorescence spectrophotometry of benzo[a]pyrene diol epoxide-DNA adducts: a tool for detection of in-vitro and in-vivo DNA damage by exposure to benzo[a]pyrene.

Vähäkangas K, Pelkonen O, Harris CC. Vähäkangas K, et al. IARC Sci Publ. 1988;(89):208-12. IARC Sci Publ. 1988. PMID: 3143671

10

The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status.

Pasanen M, Vahakangas K, Sotaniemi EA, Pelkonen O. Pasanen M, et al. Among authors: vahakangas k. Eur J Drug Metab Pharmacokinet. 1988 Jan-Mar;13(1):41-5. doi: 10.1007/BF03189927. Eur J Drug Metab Pharmacokinet. 1988. PMID: 3396613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters